These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 16669959

  • 1. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
    Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Papageorgiou A, Vassiliadis T, Giouleme O, Evgenidis N.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1443-53. PubMed ID: 16669959
    [Abstract] [Full Text] [Related]

  • 2. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C, Wiebecke B, Loeschke K.
    Am J Gastroenterol; 1999 Jun 15; 94(6):1551-5. PubMed ID: 10364024
    [Abstract] [Full Text] [Related]

  • 3. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ, Archavlis E, Christoforidis P, Kourtessas D, Amberiadis P, Florakis N, Petraki K, Spiliadi C, Triantafyllou G.
    Am J Gastroenterol; 1997 Mar 15; 92(3):454-6. PubMed ID: 9068468
    [Abstract] [Full Text] [Related]

  • 4. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F, Escribá A, Maluenda MP, López Rubio M, Margalet I, Lezana A, Gallego J, Ribera JM.
    Thromb Haemost; 2000 Oct 15; 84(4):559-64. PubMed ID: 11057850
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.
    Shen J, Ran ZH, Tong JL, Xiao SD.
    Aliment Pharmacol Ther; 2007 Sep 01; 26(5):653-63. PubMed ID: 17697199
    [Abstract] [Full Text] [Related]

  • 6. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis.
    Thomas GA, Rhodes J, Ragunath K, Mani V, Williams GT, Newcombe RG, Russell MA, Feyerabend C.
    Eur J Gastroenterol Hepatol; 1996 Aug 01; 8(8):769-76. PubMed ID: 8864674
    [Abstract] [Full Text] [Related]

  • 7. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
    Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Vassiliadis T, Mpoumponaris A, Giouleme O, Evgenidis N.
    Med Sci Monit; 2009 Nov 01; 15(11):CR563-72. PubMed ID: 19865055
    [Abstract] [Full Text] [Related]

  • 8. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H, Hammerstingl C, Paar WD, Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events.
    Med Klin (Munich); 2007 Oct 15; 102(10):809-15. PubMed ID: 17928964
    [Abstract] [Full Text] [Related]

  • 9. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB, Sandborn WJ, Kornbluth A, Katz S, Safdi M, Woogen S, Regalli G, Yeh C, Smith-Hall N, Ajayi F.
    Am J Gastroenterol; 2005 Nov 15; 100(11):2478-85. PubMed ID: 16279903
    [Abstract] [Full Text] [Related]

  • 10. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H, Videm V, Wahba A, Asberg A, Amundsen T, Bjella L, Dale O, Stenseth R.
    Eur J Cardiothorac Surg; 2006 Jun 15; 29(6):933-40. PubMed ID: 16675258
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.
    Singer MV, Schmausser H, Schönfeld G.
    Hepatogastroenterology; 2006 Jun 15; 53(69):317-21. PubMed ID: 16795963
    [Abstract] [Full Text] [Related]

  • 12. Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis.
    Pastorelli L, Saibeni S, Spina L, Signorelli C, Celasco G, de Franchis R, Vecchi M.
    Aliment Pharmacol Ther; 2008 Sep 01; 28(5):581-8. PubMed ID: 18700898
    [Abstract] [Full Text] [Related]

  • 13. Hemostatic imbalance in active and quiescent ulcerative colitis.
    van Bodegraven AA, Schoorl M, Baak JP, Linskens RK, Bartels PC, Tuynman HA.
    Am J Gastroenterol; 2001 Feb 01; 96(2):487-93. PubMed ID: 11232695
    [Abstract] [Full Text] [Related]

  • 14. Paradoxical response to heparin in 10 patients with ulcerative colitis.
    Gaffney PR, Doyle CT, Gaffney A, Hogan J, Hayes DP, Annis P.
    Am J Gastroenterol; 1995 Feb 01; 90(2):220-3. PubMed ID: 7847289
    [Abstract] [Full Text] [Related]

  • 15. Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis.
    Celasco G, Papa A, Jones R, Moro L, Bozzella R, Surace MM, Naccari GC, Gasbarrini G.
    Aliment Pharmacol Ther; 2010 Feb 01; 31(3):375-86. PubMed ID: 19891665
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.